Literature DB >> 33196321

CD4+ T cells cause renal and placental mitochondrial oxidative stress as mechanisms of hypertension in response to placental ischemia.

Evangeline Deer1, Kristin E Reeve1,2, Lorena Amaral1, Venkata Ramana Vaka1, Michael Franks1, Nathan Campbell1, Sarah Fitzgerald1, Owen Herrock1, Tarek Ibrahim1, Denise Cornelius1,3, Babbette LaMarca1,2.   

Abstract

The reduced uterine perfusion pressure (RUPP) rat model and normal pregnant (NP) rat recipients of RUPP CD4+ T cells recapitulate many characteristics of preeclampsia such as hypertension and oxidative stress. We have shown an important hypertensive role for natural killer (NK) cells to cause mitochondrial dysfunction in RUPP rats; however, the role for RUPP CD4+ T cells to stimulate NK cells is unknown. Therefore, we hypothesized that RUPP-induced CD4+ T cells activate NK cells to cause mitochondrial dysfunction/reactive oxygen species (ROS) as mechanisms of hypertension during pregnancy. We tested our hypothesis by adoptive transfer of RUPP CD4+ T cells into NP rats or by inhibiting the activation of RUPP CD4+ T cells with Orencia (abatacept) and examining hypertension, NK cells, and mitochondrial function. RUPP was performed on gestation day (GD) 14, and splenic CD4+ T cells were isolated on GD 19 and injected into NP rats on GD 13. In a separate group of rats, Orencia was infused and the RUPP procedure was performed. Mean arterial pressure and placental and renal mitochondrial ROS increased in RUPP (n = 7, P < 0.05) and NP + RUPP CD4+ T-cell recipients (n = 13, P < 0.05) compared with control NP (n = 7) and NP + NP CD4+ T-cell recipients (n = 5) but was reduced with Orencia (n = 13, P < 0.05). Placental and renal respiration was reduced in RUPP (n = 6, P < 0.05) and NP + RUPP CD4+ T-cell recipients (n = 6, state 3 P < 0.05) compared with NP (n = 5) and NP + NP CD4+ T-cell recipients (n = 5) but improved with Orencia (n = 9, n = 8 P < 0.05). These data indicate that CD4+ T cells, independent of NK cells, cause mitochondrial dysfunction/ROS contributing to hypertension in response to placental ischemia during pregnancy.

Entities:  

Keywords:  T cell; hypertension; inflammation; lymphocytes; oxidative stress; placental ischemia; preeclampsia; pregnancy

Mesh:

Substances:

Year:  2020        PMID: 33196321      PMCID: PMC7847053          DOI: 10.1152/ajprenal.00398.2020

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  25 in total

Review 1.  Immunoregulation in normal pregnancy and pre-eclampsia: an overview.

Authors:  Ian L Sargent; Angela M Borzychowski; Chris W G Redman
Journal:  Reprod Biomed Online       Date:  2006-11       Impact factor: 3.828

2.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-11       Impact factor: 7.661

3.  Inhibition of T-cell activation attenuates hypertension, TNFα, IL-17, and blood-brain barrier permeability in pregnant rats with angiogenic imbalance.

Authors:  Cynthia Bean; Shauna-Kay Spencer; Teylor Bowles; Patrick B Kyle; Jan M Williams; Jacob Gibbens; Kedra Wallace
Journal:  Am J Reprod Immunol       Date:  2016-08-01       Impact factor: 3.886

4.  Blockade of endogenous angiotensin II type I receptor agonistic autoantibody activity improves mitochondrial reactive oxygen species and hypertension in a rat model of preeclampsia.

Authors:  Venkata Ramana Vaka; Mark W Cunningham; Evangeline Deer; Michael Franks; Tarek Ibrahim; Lorena M Amaral; Nathan Usry; Denise C Cornelius; Ralf Dechend; Gerd Wallukat; Babbette D LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-11-13       Impact factor: 3.619

5.  17-Hydroxyprogesterone caproate improves T cells and NK cells in response to placental ischemia; new mechanisms of action for an old drug.

Authors:  Jamil T Elfarra; Jesse N Cottrell; Denise C Cornelius; Mark W Cunningham; Jessica L Faulkner; Tarek Ibrahim; Babbette Lamarca; Lorena M Amaral
Journal:  Pregnancy Hypertens       Date:  2019-12-02       Impact factor: 2.899

6.  Hypertension, Anxiety, and Blood-Brain Barrier Permeability Are Increased in Postpartum Severe Preeclampsia/Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome Rats.

Authors:  Kedra Wallace; Cynthia Bean; Teylor Bowles; Shauna-Kay Spencer; Wisdom Randle; Patrick B Kyle; James Shaffery
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

7.  Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats.

Authors:  Mona Sedeek; Jeffrey S Gilbert; Babbette B LaMarca; Myssara Sholook; Derrick L Chandler; Yuping Wang; Joey P Granger
Journal:  Am J Hypertens       Date:  2008-07-31       Impact factor: 2.689

Review 8.  Identifying immune mechanisms mediating the hypertension during preeclampsia.

Authors:  Babbette LaMarca; Denise C Cornelius; Ashlyn C Harmon; Lorena M Amaral; Mark W Cunningham; Jessica L Faulkner; Kedra Wallace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-20       Impact factor: 3.619

Review 9.  Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia.

Authors:  Keiichi Matsubara; Takashi Higaki; Yuko Matsubara; Akihiro Nawa
Journal:  Int J Mol Sci       Date:  2015-03-02       Impact factor: 5.923

Review 10.  Endothelial dysfunction and preeclampsia: role of oxidative stress.

Authors:  Lissette C Sánchez-Aranguren; Carlos E Prada; Carlos E Riaño-Medina; Marcos Lopez
Journal:  Front Physiol       Date:  2014-10-10       Impact factor: 4.566

View more
  6 in total

1.  Dietary protein source contributes to the risk of developing maternal syndrome in the Dahl salt-sensitive rat.

Authors:  John Henry Dasinger; Justine M Abais-Battad; John D Bukowy; Hayley Lund; Ammar J Alsheikh; Daniel J Fehrenbach; Jeylan Zemaj; David L Mattson
Journal:  Pregnancy Hypertens       Date:  2021-05-05       Impact factor: 2.494

2.  Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy.

Authors:  Evangeline Deer; Jalisa Jones; Denise C Cornelius; Kyleigh Comley; Owen Herrock; Nathan Campbell; Sarah Fitzgerald; Tarek Ibrahim; Babbette LaMarca; Lorena M Amaral
Journal:  Cells       Date:  2021-10-20       Impact factor: 7.666

3.  Low Dose of IL-2 Normalizes Hypertension and Mitochondrial Function in the RUPP Rat Model of Placental Ischemia.

Authors:  Evangeline Deer; Lorena M Amaral; Nathan Campbell; Sarah Fitzgerald; Owen Herrock; Tarek Ibrahim; Babbette LaMarca
Journal:  Cells       Date:  2021-10-19       Impact factor: 7.666

Review 4.  Is Mitochondrial Oxidative Stress a Viable Therapeutic Target in Preeclampsia?

Authors:  Ramana Vaka; Evangeline Deer; Babbette LaMarca
Journal:  Antioxidants (Basel)       Date:  2022-01-22

5.  The role of tumor necrosis factor in triggering activation of natural killer cell, multi-organ mitochondrial dysfunction and hypertension during pregnancy.

Authors:  Aswathi Jayaram; Evangeline Deer; Lorena M Amaral; Nathan Campbell; Venkata Ramana Vaka; Mark Cunningham; Tarek Ibrahim; Denise C Cornelius; Babbette B LaMarca
Journal:  Pregnancy Hypertens       Date:  2021-02-16       Impact factor: 2.494

6.  Deficiency in CD4 T Cells Leads to Enhanced Postpartum Internal Carotid Artery Vasoconstriction in Mice: The Role of Nitric Oxide.

Authors:  Natalia I Gokina; Rebecca I Fairchild; Kirtika Prakash; Nicole M DeLance; Elizabeth A Bonney
Journal:  Front Physiol       Date:  2021-06-16       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.